Blog | November 16, 2012

Melinda sample blog post

The annual Transcatheter Cardiovascular Therapeutics meeting is a key source of the latest clinical trial data on new stent technologies. Two key trials were presented, published in the Cardiology Journal, each using transcatheter patent foramen ovale (PFO) closure to prevent cryptogenic strokes.

One late-breaking trial illustrated an effective way to reduce contrast-induced nephropathy in renally impaired patients. Click here to see the presentation of the POSEIDON Trial.

Stories and videos on these topics can be found below.